Company Filing History:
12 out of 12 
1 out of 1 
8 out of 832,912 Years Active: 2016-2024
Title: **Tse-Wen Chang: Innovator in Composite Polypeptide Technologies**
Introduction
Tse-Wen Chang is a distinguished inventor based in Taipei, Taiwan, with an impressive portfolio of 21 patents. His innovative contributions in the field of composite polypeptides have implications for pharmaceutical and biotechnological advancements. Chang's work is marked by a commitment to enhancing molecular constructs, which can lead to novel therapeutic solutions.
Latest Patents
Among Tse-Wen Chang's recent patents are two significant innovations. The first is titled "Composite Polypeptide Having a Metal Binding Motif and Molecular Construct Comprising the Same." This patent describes a composite polypeptide that includes a parent polypeptide and a metal binding motif capable of forming a complex with a metal cation. The versatility of this innovation is highlighted by its potential for conjugation with linker units that contain multiple functional elements, allowing for the creation of multi-functional molecular constructs.
The second patent, "Core Constructs and Their Uses in Configuring Pharmaceutical Molecules," provides details on various core constructs that can be used to develop pharmaceutical molecules. This innovation emphasizes the ability to conjugate core constructs with functional elements through click chemistry, paving the way for enhanced pharmaceutical design and application.
Career Highlights
Tse-Wen Chang has made substantial contributions to the field throughout his career, particularly through his work at Immunwork Inc. His ongoing commitment to research and development has positioned him as a key figure in the biotechnology sector. His expertise in polypeptide chemistry has gained recognition, leading to multiple patents that address critical challenges in pharmaceutical sciences.
Collaborations
Throughout his career, Tse-Wen Chang has collaborated with esteemed professionals such as Hsing-Mao Chu and Chun-Yu Lin. These partnerships have fostered an environment of creativity and innovation, enabling the exploration of groundbreaking ideas and solutions in the realm of molecular constructs and pharmaceuticals.
Conclusion
Tse-Wen Chang's inventive spirit and dedication to advancing composite polypeptide technologies exemplify the impact of innovative research in the pharmaceutical industry. With 21 patents to his name, his contributions are paving the way for future innovations in drug development and molecular engineering. As the field progresses, Chang's work will continue to inspire and influence the next generation of inventors and researchers.